Climate models have been under-predicting the northward march of Aedes by roughly a decade

title: "Climate models have been under-predicting the northward march of Aedes by roughly a decade" date: "2026-04-15" author: "Mosticare Editorial" authorRole: "Vector Ecology · Mosticare Foundation" mins: 12 region: "Europe" alert: null excerpt: "Aedes albopictus is now established in cities that climate models placed outside its range until the 2030s. The models were not wrong, the climate moved faster. Here is what the revised projections look like, and what they mean for northern Europe." sources:

• text: "Kraemer et al. 2019 · Global spread of Aedes albopictus, eLife" href: "https://doi.org/10.7554/eLife.34584"
• text: "ECDC 2024 · Aedes albopictus current range map" href: "https://www.ecdc.europa.eu/en/disease-vectors/facts/mosquito-maps"
• text: "Mordecai et al. 2017 · Thermal optimum for dengue transmission, PLOS NTD" href: "https://doi.org/10.1371/journal.pntd.0005568"
• text: "European Environment Agency 2025 · European Climate Risk Assessment" href: "https://www.eea.europa.eu"
• text: "Copernicus Climate Change Service · ERA5 reanalysis 2025" href: "https://climate.copernicus.eu" correctionEmail: "corrections@mosticare.org"

In 2012, the European Centre for Disease Prevention and Control published range projections for Aedes albopictus in Europe based on climate envelope modelling using A1B emissions scenarios. The projections showed the tiger mosquito reaching the Rhine Valley by 2030–2040, establishing in the Netherlands and Belgium by 2040–2050, and potentially appearing in southern England and Denmark by mid-century.

Aedes albopictus reached the Rhine Valley in 2019. It was confirmed in the Netherlands in 2023. It is now being trapped at Rotterdam's port and in three Frankfurt-area municipalities. In April 2026, sustained populations have been confirmed inland of Frankfurt — a location the 2012 model placed outside the establishment range until approximately 2035.

The models were not wrong. The climate moved faster.

What the models predicted and what happened

Climate envelope models for mosquito species project establishment based on three primary variables: mean summer temperature, minimum winter temperature (which determines overwintering survival), and annual precipitation pattern. Aedes albopictus has a lower thermal limit of approximately 10°C for adult activity and requires mean minimum winter temperatures above −2°C for population persistence.

The 2012 ECDC projections used temperature anomaly forecasts from the IPCC AR4 report. By 2025, observed temperature anomalies across Central Europe were tracking at the upper bound of the AR4 high-emissions scenario, a trajectory that the modellers acknowledged as possible but treated as the pessimistic case.

The gap between the projected and observed range expansion in 2026 is approximately 8–12 years, meaning the mosquito is where the model said it would be a decade from now. This is not model failure. It is the observed climate running ahead of the scenario that drove the model.

The revised picture for northern Europe

Using the Copernicus ERA5 reanalysis dataset and current ECDC monitoring data, we can update the range envelope:

Already established (2026): Italy, Spain, France, Switzerland, Slovenia, Croatia, Austria (south), Germany (Rhine Valley and now Hessen), Netherlands (coast and Rotterdam area).

Projected establishment by 2028–2030: Belgium, Luxembourg, Czech Republic (Bohemia), Slovakia, Hungary, southern Poland, Denmark (Jutland coast).

Projected establishment by 2033–2037: Southern Sweden (Skåne), Baltic coastal zones, Ireland (south), UK (Greater London, south coast).

These projections carry genuine uncertainty, both because overwintering success is nonlinear at thermal limits, and because human-assisted introduction (via used tyre trade, ornamental plant transport, and vehicle movement) can accelerate establishment ahead of climate suitability.

The transmission gap

Range expansion is necessary but not sufficient for disease transmission. Aedes albopictus needs to reach viral titres high enough to transmit dengue or chikungunya before the end of its gonotrophic cycle, which becomes increasingly likely as summer temperatures rise above the dengue thermal optimum of approximately 29°C.

The Mordecai et al. 2017 thermal optimum models suggest that dengue transmission efficiency in Aedes albopictus peaks at 29°C and remains meaningfully high between 22°C and 34°C. The number of days per summer where temperatures in Cologne, Frankfurt, and Vienna exceed 22°C has increased by approximately 18 days per decade since 1990. By 2030, Central European cities are projected to spend 60–80 days per summer above this threshold, compared to 20–30 days in the 1990s.

This is the transmission gap closing. Not quickly enough to cause mass epidemics in Germany in 2026. Quickly enough that the public-health infrastructure that would be needed to contain a 2030 or 2035 outbreak does not yet exist in northern Europe.

What this means practically

The policy question is not whether northern Europe will experience vector-borne disease transmission, it is when, and how prepared the healthcare and public-health systems will be when it arrives.

The evidence suggests that the answer to "when" has moved forward by roughly a decade from the estimates that informed the last round of national preparedness planning. Most northern European countries prepared vector-borne disease response plans in the 2015–2020 window based on projections that placed meaningful exposure risk in the 2040s. Those plans need to be revised against the current evidence.

For European households in the affected zone, the implications are immediate and practical:

• Physical-barrier protection, window screens, door screens, bed nets, is no longer a concern for travellers to the tropics only. It is a precaution for sleeping in an unscreened room in Frankfurt, the Netherlands, or Vienna in July.
• Standing-water elimination is the single most effective intervention at household level. Aedes breeds in containers as small as a bottle cap. The species is exquisitely adapted to the urban garden.
• If you develop dengue-compatible symptoms (sudden high fever, severe headache, retroorbital pain, myalgia) in summer months in central Europe, mention your local mosquito exposure to your GP. Differential diagnosis still tends to exclude vector-borne disease in northern European clinical settings.

The mosquito is not waiting for northern Europe to update its threat model. The model needs to update first.